Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach.

Human pathology - 1 Jun 2021

Parra Ourania, Lefferts Joel A, Tafe Laura J, Gru Alejandro A, Linos Konstantinos

Abstract excerpt

The most recent World Health Organization classification for skin tumors (2018) categorizes melanomas and their precursor lesions, benign or intermediate, into nine pathways based not only on their clinical and histomorphologic characteristics but also on their molecular profile and genetic fingerprint. In an index case of a partially sampled atypical spitzoid lesion, which proved to be an 11p-amplified Spitz...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Chromosomes, Human, Pair 11

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross Reactions

Share to Diagnosis, Differential

Share to GTP Phosphohydrolases

Share to Melanoma

Share to Proto-Oncogene Proteins p21(ras)

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 33636207
DOI: 10.1016/j.humpath.2021.02.001
PMCID: PMC10947247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach.PMID 33636207Read ↗

Spitz melanocytic tumours – a reviewSemantic proximity Read ↗

Kinase Fusions in Spitz Melanocytic Tumors: The Past, the Present, and the FutureSemantic proximity Read ↗

HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features.Semantic proximity Read ↗

Spitz melanoma is a distinct subset of spitzoid melanoma.Semantic proximity Read ↗

Amplification of Mutant NRAS in Melanocytic Tumors With Features of Spitz Tumors.Semantic proximity Read ↗

Toward a Molecular-Genetic Classification of Spitzoid Neoplasms.Semantic proximity Read ↗

Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1.Semantic proximity Read ↗

Attempting to Solve the Pigmented Epithelioid Melanocytoma (PEM) ConundrumSemantic proximity Read ↗

Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.Semantic proximity Read ↗

The Morpho-Molecular Landscape of Spitz Neoplasms.Semantic proximity Read ↗

Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.Semantic proximity Read ↗

The Extended Spectrum of Morphologic and Molecular Findings in ALK Fusion Spitz Neoplasms : A Study of 144 Cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.